Xcout Intel
Phage Technologies
Phage Technologies advances safe, effective, and scalable phage technologies and services from Finland to combat global health threats such as antibiotic resistance.
Subscribe to see Phage Technologies’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Phage Technologies at a glance
Phage Technologies is a biotechnology company headquartered in Finland. Xcout tracks 18 named people at Phage Technologies, including Matti Jalasvuori (Chief Executive Officer (CEO)).
Phage Technologies leadership
- Matti JalasvuoriChief Executive Officer (CEO)
- Johanna EkholmChief Compliance Officer
- Olli PitkänenChief Development Officer
- Pauliina LajunenChief Business Officer
- Ville HoikkalaChief Information Technology Officer
- Aditya JeevannavarBioinformatician
12 more named people on record for Phage Technologies, with roles, board committees and tenure — see the full roster →
Phage Technologies competitors
A few of Phage Technologies's closest competitors — see the full list of competitors and alternatives →
Adaptive Phage Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in Gaithersburg, Maryland, that is advancing the APT phage bank. The company focuses on developing phage-based therapeutics to address bacterial infections.
Founded in 2021 and located in Suresnes, France, Phagos is a biotechnology research company specializing in AI-native phage therapy. The firm creates personalized bacterial treatments as a sustainable alternative to antibiotics.
Obulytix is a biotechnology startup founded in 2023 and headquartered in Ghent, Belgium, focused on advancing antimicrobial innovation and building the future of antibiotics.
TILT Biotherapeutics is a Finnish biotechnology company developing tumor-targeted immunotherapies, including oncolytic adenoviruses designed to stimulate immune responses against solid tumors. Its therapies are intended for cancer patients and are developed through clinical and pharmaceutical partnerships.
Primal Therapies, Inc. is a biotechnology company specializing in microbial technology and expertise, with its primary location in Minneapolis, Minnesota.
BioVersys AG is an award-winning, privately-owned Swiss pharmaceutical and biotech company headquartered in Basel, Switzerland, focused on the research and development of antibacterial treatments for drug-resistant bacterial infections.
Get Phage Technologies's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Phage Technologies in Xcout Intel
- 18 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access